Ferrous fumarate

Generic Name: Ferrous fumarate

Brand Names: Aurovela Fe, Concept Ob, Hailey Fe 1.5/30 28 Day, Hematogen, Microgestin Fe 1/20 28 Day, Pregvit, Tandem, Tandem Plus, Tarina 24 Fe 1/20 28 Day

Drug Type: Small Molecule

Chemical Formula: C_₄H_₂FeO_₄

CAS Number: 141-01-5

Unique Ingredient Identifier: R5L488RY0Q

Background: Used in treatment of iron deficiency anemia.

Indication: Used in preventing and treating iron-deficiency anemia.

Associated Conditions: Folic acid antagonist overdose, Iron Deficiency (ID), Iron Deficiency Anemia (IDA)

Associated Therapies: Oral Contraceptives

Clinical Trials

Oral Versus Intravenous Iron in IBD Patients With Anti-inflammatory Therapy.

Not Applicable

Recruiting

Conditions: Inflammatory Bowel Diseases

Interventions: Drug: Ferrous fumarate
Drug: MonoFer

First Posted Date: 2022-10-14

Last Posted Date: 2022-10-14

Lead Sponsor: Leiden University Medical Center

Target Recruit Count: 152

Registration Number: NCT05581420

Locations: 🇳🇱
Leiden University Medical Centre, Leiden, Zuid-Holland, Netherlands

Predicting Response to Iron Supplementation in Patients With Active Inflammatory Bowel Disease

Phase 4

Recruiting

Conditions: Inflammatory Bowel Diseases
Iron Deficiency Anemia
Iron-deficiency

Interventions: Drug: Ferric maltol
Drug: Intravenous iron
Drug: Ferrous fumarate

First Posted Date: 2022-07-13

Last Posted Date: 2023-03-31

Lead Sponsor: Leiden University Medical Center

Target Recruit Count: 90

Registration Number: NCT05456932

Locations: 🇳🇱
Radboud University Medical Center, Nijmegen, Netherlands
🇳🇱
University Medical Center Groningen, Groningen, Netherlands
🇳🇱
Maastricht University Medical Center+, Maastricht, Netherlands

and more 2 locations

The Efficacy of Intermittent Versus Daily Oral Iron Supplementation in Anaemic Pregnant Women.

Phase 4

Conditions: Iron Deficiency Anemia
Pregnancy Related

Interventions: Drug: Ferrous fumarate

First Posted Date: 2022-03-14

Last Posted Date: 2022-03-14

Lead Sponsor: Martini Hospital Groningen

Target Recruit Count: 58

Registration Number: NCT05278793

Locations: 🇳🇱
Martini Hospital Groningen, Groningen, Netherlands

Thrice-weekly Versus Thrice-daily Oral Ferrous Fumarate Treatment in Adult Patients With Iron Deficiency Anemia

Phase 3

Completed

Conditions: Iron Deficiency Anemia

Interventions: Drug: Ferrous Fumarate

First Posted Date: 2019-10-17

Last Posted Date: 2022-02-15

Lead Sponsor: Prince of Songkla University

Target Recruit Count: 66

Registration Number: NCT04130828

Locations: 🇹🇭
Songklanagarind Hospital, Hat Yai, Songkhla, Thailand

Preoperative Intravenous Iron Infusion to Reduce Post-surgical Complications: a Pilot Randomised Control Trial

Phase 4

Conditions: Anemia
Pre-operative
Major Abdominal Surgery

Interventions: Drug: Ferric carboxymaltose
Drug: Ferrous Fumarate

First Posted Date: 2017-09-28

Last Posted Date: 2018-12-05

Lead Sponsor: Singapore General Hospital

Target Recruit Count: 60

Registration Number: NCT03295851

Locations: 🇸🇬
Singapore General Hospital, Singapore, Singapore

Iron Dextran Versus Oral Iron for Treating Iron Deficiency Anemia in Pregnant Women

Phase 3

Completed

Conditions: Anemia

Interventions: Drug: Ferrous Fumarate
Drug: Iron dextran

First Posted Date: 2017-07-11

Last Posted Date: 2017-07-11

Lead Sponsor: Assiut University

Target Recruit Count: 66

Registration Number: NCT03212781

Locations: 🇪🇬
Assiut Faculty of Medicine, Assiut, Egypt

Optimizing Iron Suppletion After Roux-en-Y Gastric Bypass

Phase 4

Completed

Conditions: Iron Deficiency

Interventions: Drug: Iron(III)carboxymaltose
Drug: Ferrous fumarate
Drug: Ferrous gluconate

First Posted Date: 2014-10-22

Last Posted Date: 2019-01-18

Lead Sponsor: Rijnstate Hospital

Target Recruit Count: 120

Registration Number: NCT02271997

Locations: 🇳🇱
Rijnstate hospital, Arnhem, Netherlands
🇳🇱
Rose Kruis Ziekenhuis, Beverwijk, Netherlands
🇳🇱
OLVG West/ Sint Lucas Andreas Ziekenhuis, Amsterdam, Noord-Holland, Netherlands

Trial Comparing Ferric(III)Carboxymaltose Infusion With Oral Iron Suppletion as Treatment of Anaemia

Phase 4

Conditions: Anemia
Colorectal Carcinoma
Surgery

Interventions: Drug: ferric(III)carboxymaltose
Drug: Ferrous fumarate

First Posted Date: 2014-09-18

Last Posted Date: 2018-08-28

Lead Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Target Recruit Count: 198

Registration Number: NCT02243735

Locations: 🇳🇱
Medisch Centrum Alkmaar, Alkmaar, Netherlands
🇳🇱
Flevoziekenhuis, Almere, Netherlands
🇳🇱
Meander Ziekenhuis, Amersfoort, Netherlands

and more 9 locations

Iron Absorption Trial

Phase 4

Completed

Conditions: Iron Absorption
Bariatric Surgery
Roux- en -y Gastric Bypass

Interventions: Drug: Ferrous fumarate
Drug: Ferrous gluconate

First Posted Date: 2014-08-29

Last Posted Date: 2020-06-11

Lead Sponsor: Rijnstate Hospital

Target Recruit Count: 24

Registration Number: NCT02228902

Locations: 🇳🇱
Rijnstate hospital, Arnhem, Netherlands

The Use of Iron Therapy for Patients With Anemia After Caesarean Section

Phase 4

Terminated

Conditions: Postoperative Anaemia

Interventions: Drug: Ferinject
Drug: Ferrous fumarate
Drug: Placebo for ferrous fumarate
Drug: Placebo for ferinject

First Posted Date: 2013-11-03

Last Posted Date: 2022-08-22

Lead Sponsor: Maastricht University Medical Center

Target Recruit Count: 27

Registration Number: NCT01975272

Locations: 🇳🇱
Maastricht University Medical Centre, Maastricht, Limburg, Netherlands
🇳🇱
Orbis Medical Centre, Sittard, Limburg, Netherlands

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy